pentobarbital will lessen the extent or effect of linagliptin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Use of alternative therapies is strongly proposed when linagliptin should be to be administered with a CYP3A4 inducerpentobarbital will lower the level or result of disopyramide by influencing hepatic/intestin